Zantac Lawsuit


Researching drug company and regulatory malfeasance for over 16 years
Humanist, humorist

Saturday, August 22, 2009

ABILIFY - LIKELY TO DRIVE YOU INSANE!

With more and more reports coming in of adverse reactions to SSRi's such as Prozac and Seroxat and non-SSRi's like Effexor, you may be surprised to learn that ABILIFY is designed to help people already on antidepressants!

According to the advertisement, 2 out of 3 people being treated for depression still have depression symptoms.

If it wasn't so serious this would be laughable. I'm scratching my head at ways to write about ABILIFY. The marketing defies all belief - it's basically saying 2 out of 3 people on antidepressants are... um...still depressed and because they are still depressed they need more drugs on top of the one's they are already taking. In other words - a chemical lobotomy.

Don't worry though folks, the advertisement carries the reassuring news that ALBILFY is FDA approved to treat depression in adults when added to an antidepressant [such as Lexapro, Zoloft, Effexor XR or Paxil CR]

The ad shows a young woman staring into space with the words, "I'm taking an antidepressant, but I think I might need more help"

Then comes the money line:

"Approximately 2 out of 3 people being treated for depression still have depression symptoms. If an antidepressant alone isn't enough, talk to your doctor. Your options may include adding ABILFY to the antidepressant you're already taking."

It's an advertisement that raises bile and gives you a taste of vomit in the mouth, it's akin to giving the owner of a gun an extra bullet - just in case the 6 bullets they already had, didn't do the job!

I'm not astounded anymore. Pharmaceutical companies are literally getting away with murder - the regulators [enforcers] are allowing them to.

ABILIFY is a product of Bristol-Myers Squibb.



Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

2 comments:


Please contact me if you would like a guest post considered for publication on my blog.